Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
Merli M, Luminari S, Farina L, Cocito F, Defrancesco I, Gini G, Arcari A, Scapinello G, Gentile M, Goldaniga M, Loseto G, Cencini E, Greco A, Molinari AL, Ferrario A, Bianchi B, Mora B, Bertù L, Saturni V, Bergamini F, Fabbri N, Rossi FG, Bolis S, Passamonti F, Arcaini L. Merli M, et al. Among authors: fabbri n. Bone Marrow Transplant. 2020 Dec;55(12):2350-2353. doi: 10.1038/s41409-020-0967-5. Epub 2020 Jun 15. Bone Marrow Transplant. 2020. PMID: 32541690 No abstract available.
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis.
Defrancesco I, Zibellini S, Boveri E, Frigeni M, Ferretti VV, Rizzo E, Bonometti A, Capuano F, Candido C, Rattotti S, Tenore A, Picone C, Flospergher E, Zerbi C, Bergamini F, Fabbri N, Cristinelli C, Varettoni M, Paulli M, Arcaini L. Defrancesco I, et al. Among authors: fabbri n. Hematol Oncol. 2020 Dec;38(5):689-697. doi: 10.1002/hon.2784. Epub 2020 Aug 19. Hematol Oncol. 2020. PMID: 32738175
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies.
Varettoni M, Ferrari A, Frustaci AM, Ferretti VV, Rizzi R, Motta M, Piazza F, Merli M, Benevolo G, Visco C, Laurenti L, Ferrero S, Gentile M, Del Fabro V, Abbadessa A, Klersy C, Musto P, Fabbri N, Deodato M, Dogliotti I, Greco C, Corbingi A, Luminari S, Arcaini L. Varettoni M, et al. Among authors: fabbri n. Am J Hematol. 2020 Dec;95(12):1473-1478. doi: 10.1002/ajh.25961. Epub 2020 Sep 9. Am J Hematol. 2020. PMID: 32780514 Free article. Clinical Trial.
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders.
Defrancesco I, Visentini M, Zibellini S, Minafò YA, Rattotti S, Ferretti VV, Rizzo E, Varettoni M, Frigeni M, Pulsoni A, Casato M, Colantuono S, Rossi M, Candido C, Zerbi C, Bergamini F, Cristinelli C, Fabbri N, Merli M, Zuccaro V, Bruno R, Paulli M, Arcaini L. Defrancesco I, et al. Among authors: fabbri n. Am J Hematol. 2021 Jun 1;96(6):E210-E214. doi: 10.1002/ajh.26167. Epub 2021 Apr 9. Am J Hematol. 2021. PMID: 33755245 Free PMC article. No abstract available.
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemia.
Varettoni M, Orlandi E, Zibellini S, Rossi M, Gentile M, Flospergher E, Ferretti VV, Rizzo E, Della Porta MG, Rattotti S, Cavalloni C, Bergamini F, Cristinelli C, Fabbri N, Gallì A, Arcaini L. Varettoni M, et al. Among authors: fabbri n. Am J Hematol. 2021 Nov 1;96(11):E404-E408. doi: 10.1002/ajh.26302. Epub 2021 Aug 11. Am J Hematol. 2021. PMID: 34329489 Free article. No abstract available.
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study.
Varettoni M, Zibellini S, Merli M, Drandi D, Jiménez C, Furlan D, Ferretti VV, Fabbri N, Dogliotti I, Varraso C, Ferrante M, Cappello E, Peri V, Cavalloni C, Borriero M, Facchetti GV, Ferrero S, Arcaini L, Garcia-Sanz R. Varettoni M, et al. Among authors: fabbri n. Hematol Oncol. 2023 Aug;41(3):574-577. doi: 10.1002/hon.3082. Epub 2022 Oct 19. Hematol Oncol. 2023. PMID: 36218059 No abstract available.
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment.
Arcaini L, Bommier C, Alderuccio JP, Merli M, Fabbri N, Nizzoli ME, Maurer MJ, Tarantino V, Ferrero S, Rattotti S, Talami A, Murru R, Khurana A, Mwangi R, Deodato M, Cencini E, Re F, Visco C, Feldman AL, Link BK, Delamain MT, Spina M, Annibali O, Pulsoni A, Ferreri AJM, Stelitano CC, Pennese E, Habermann TM, Marcheselli L, Han S, Reis IM, Paulli M, Lossos IS, Cerhan JR, Luminari S. Arcaini L, et al. Among authors: fabbri n. EClinicalMedicine. 2024 Apr 11;72:102592. doi: 10.1016/j.eclinm.2024.102592. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38633575 Free PMC article.
The EUropean PErioperative MEdical networking (EUPEMEN) project: recommendations for perioperative care in colorectal surgery. a quality improvement study.
Pesce A, Ramírez JM, Fabbri N, Martínez Ubieto J, Pascual Bellosta A, Arroyo A, Sánchez-Guillén L, Whitley A, Kocián P, Rosetzka K, Bona Enguita A, Ioannidis O, Bitsianis S, Symeonidis S, Anestiadou E, Teresa-Fernandéz M, Vittorio Feo C. Pesce A, et al. Among authors: fabbri n. Int J Surg. 2024 May 13. doi: 10.1097/JS9.0000000000001601. Online ahead of print. Int J Surg. 2024. PMID: 38742840
188 results